Progress of ERK Pathway-Modulated Natural Products for Anti-Non-Small-Cell Lung Cancer Activity
Open Access
- 12 September 2025
- journal article
- review article
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (9) , 1371
Abstract
In recent decades, there has been a significant increase in new lung cancer cases and deaths globally, especially in China, which hindered the extension of human life expectancy and severely threatened public health. Natural products are important and sustainable sources of new anticancer drug molecules, offering new bioactive molecules with various structures and biofunctions for new anticancer drug development, which accounted for 40% of all anticancer drugs. Natural-based compounds could inhibit cancer cell proliferation and migration through a variety of anticancer mechanisms by the modulation/regulation of multiple biotargets and cell signaling pathways. In this review, we summarized the anticancer activities of flavonoids, terpenoids, glycosides, alcohols, coumarins, saccharides, and other natural compounds that could modulate the ERK-related signaling pathway in non-small-cell lung cancer (NSCLC) cells. We further elucidated the mechanistic pathways of natural compound combinations and computationally predicted their molecular docking affinities with ERK1/ERK2 protein targets, as well as providing an outlook on current studies, with the expectation that natural compounds will play more significant roles in future antitumor chemotherapy regimens.Keywords
Funding Information
- National Natural Science Foundation of China (81502955, 82173731, UIDP/00674/2020, UIDB/00674/2020, 2021. 00453.CEECIND)
- CSPFTZ Lingang Special Area Marine Biomedical Innovation Platform (81502955, 82173731, UIDP/00674/2020, UIDB/00674/2020, 2021. 00453.CEECIND)
- Shanghai Municipal Education Commission (AI-Driven Research Paradigm Reform & Advance Plan) (81502955, 82173731, UIDP/00674/2020, UIDB/00674/2020, 2021. 00453.CEECIND)
- FCT-Fundação para a Ciência e a Tecnologia (81502955, 82173731, UIDP/00674/2020, UIDB/00674/2020, 2021. 00453.CEECIND)
- ARDITI-Agência Regional para o Desenvolvimento da Investigação Tecnologia e Inovação (81502955, 82173731, UIDP/00674/2020, UIDB/00674/2020, 2021. 00453.CEECIND)
This publication has 99 references indexed in Scilit:
- The antitumor effect of hinesol, extract from Atractylodes lancea (Thunb.) DC. by proliferation, inhibition, and apoptosis induction via MEK/ERK and NF‐κB pathway in non–small cell lung cancer cell lines A549 and NCI‐H1299Journal of Cellular Biochemistry, 2019
- Toosendanin, a natural product, inhibited TGF‐β1‐induced epithelial‐mesenchymal transition through ERK/Snail pathwayPhytotherapy Research, 2018
- Lupeol and Its Role in Chronic Diseases2016
- Cinnamomum cassiaessential oil and its major constituent cinnamaldehyde induced cell cycle arrest and apoptosis in human oral squamous cell carcinomaHSC‐3 cellsEnvironmental Toxicology, 2016
- Oroxylin A inhibits invasion and migration through suppressing ERK/GSK‐3β signaling in snail‐expressing non‐small‐cell lung cancer cellsMolecular Carcinogenesis, 2016
- Dioscin-induced autophagy mitigates cell apoptosis through modulation of PI3K/Akt and ERK and JNK signaling pathways in human lung cancer cell linesArchives of Toxicology, 2013
- Salidroside attenuates inflammatory responses by suppressing nuclear factor-κB and mitogen activated protein kinases activation in lipopolysaccharide-induced mastitis in miceInflammation Research, 2012
- Rapid Analysis of Abietanes in ConifersJournal of Chemical Ecology, 2006
- Adaptogenic and central nervous system effects of single doses of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in micePhytotherapy Research, 2006
- Antioxidant activity of Cinnamomum cassiaPhytotherapy Research, 2003